GENE ONLINE|News &
Opinion
Blog

2018-03-07|

7 March, 1938: American biologist David Baltimore was born

by GeneOnline
Share To

American biologist David Baltimore (7 March, 1938 – present) is currently the President Emeritus and Robert Andrews Millikan Professor of Biology. After Renato Dulbecco discovered that tumor viruses operate by incorporating their DNA into the DNA of host cells, David Baltimore and Howard Temin – independently of one another – discovered that viruses with genomes consisting of RNA can also be inserted into host cells’ DNA. This takes place through an enzyme known as “reverse transcriptase”. The discovery that the information in RNA can be transferred to DNA meant that the generally accepted rule that genetic information was only transferred in one direction – from DNA to RNA, to protein – had to be modified. This finding led them to the Nobel Prize in Physiology or Medicine in 1975. David Baltimore was only 37 that year.

Reference
https://www.bbe.caltech.edu/content/david-baltimore

Image Source
https://commons.wikimedia.org/wiki/File:Dr._David_Baltimore1.jpg#file

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
R&D
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
R&D
Bacteriophage Characteristics Could Provide the Key to Tackling Viruses
2022-11-02
LATEST
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
EVENT
Scroll to Top